Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$24.32 -0.16 (-0.65%)
At close: Sep 22, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Liabilities and Shareholders Equity (2013 - 2026)

Amphastar Pharmaceuticals (AMPH) posted Liabilities and Shareholders Equity of $1.7 billion for Q2 2026, up 5.8% on a QoQ basis from $1.6 billion in Q1 2026, and up 7.95% year-over-year from $1.6 billion in Q2 2025.

Analysis

Amphastar Pharmaceuticals (AMPH) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends

Amphastar Pharmaceuticals has reported Liabilities and Shareholders Equity for 14 years, with the latest figure at $1.7 billion in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 7.95% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $6.7 billion, a 5.08% increase from a year earlier, with the FY2025 full-year figure at $1.6 billion, up 3.29% from the prior year.
  • Liabilities and Shareholders Equity was $1.7 billion for Q2 2026 at Amphastar Pharmaceuticals, up from $1.6 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $1.7 billion in Q2 2026, with the low at $716.2 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.3 billion, with a median of $1.5 billion recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity jumped 112.56% in 2023, then advanced 0.04% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $742.0 million in 2022, then surged by 103.9% to $1.5 billion in 2023, then rose by 4.27% to $1.6 billion in 2024, then climbed by 3.29% to $1.6 billion in 2025, then increased by 7.03% to $1.7 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $1.7 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 39.86 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 35.04 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 6.08 Bn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 3.78 Bn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 24.79 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 1.49 Bn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 1.59 Bn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 1.74 Bn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 75.75 Mn
10 NutriBand 94.45 Mn 91.03 Mn 181,874.00 6.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Bn
Mar 31, 2026 1.65 Bn
Dec 31, 2025 1.63 Bn
Sep 30, 2025 1.67 Bn
Jun 30, 2025 1.62 Bn
Mar 31, 2025 1.63 Bn
Dec 31, 2024 1.58 Bn
Sep 30, 2024 1.55 Bn
Jun 30, 2024 1.49 Bn
Mar 31, 2024 1.57 Bn
Dec 31, 2023 1.51 Bn
Sep 30, 2023 1.54 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 773.66 Mn
Dec 31, 2022 741.99 Mn
Sep 30, 2022 726.70 Mn
Jun 30, 2022 723.72 Mn
Mar 31, 2022 716.24 Mn
Dec 31, 2021 671.53 Mn
Sep 30, 2021 651.68 Mn
API Access

Amphastar Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AMPH&period=max&api_key=YOUR_API_KEY